Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2906)
All Articles published online
|
Jul 28, 2007 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kosmider S, Lipton L. Adjuvant therapies for colorectal cancer. World J Gastroenterol 2007; 13(28): 3799-3805 [PMID: 17657833 DOI: 10.3748/wjg.v13.i28.3799] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i28/3799.htm |
| Number | Citing Articles |
| 1 |
Kuan-Yin Lin, Shiow-Ching Shun, Yeur-Hur Lai, Jin-Tung Liang, Jau-Yih Tsauo. Comparison of the Effects of a Supervised Exercise Program and Usual Care in Patients With Colorectal Cancer Undergoing Chemotherapy. Cancer Nursing 2014; 37(2): E21 doi: 10.1097/NCC.0b013e3182791097
|
| 2 |
Manuel Campos de Gouveia, Laura Elisabete Ribeiro Barbosa. Timing of neoadjuvant therapy and surgical treatment in rectal cancer. Journal of Coloproctology 2019; 39(02): 178 doi: 10.1016/j.jcol.2018.11.003
|
| 3 |
P. N. Siriwardana, A. Pathmeswaran, J. Hewavisenthi, K. I. Deen. Histopathology reporting in colorectal cancer: a proforma improves quality. Colorectal Disease 2009; 11(8): 849 doi: 10.1111/j.1463-1318.2008.01680.x
|
| 4 |
Winnie Lai Ting Kan, Chun Yin, Hong Xi Xu, Gang Xu, Kenneth Kin Wah To, Chi Hin Cho, John Anthony Rudd, Ge Lin. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1‐mediated G0/G1 cell cycle arrest and apoptosis. International Journal of Cancer 2013; 132(3): 707 doi: 10.1002/ijc.27694
|
| 5 |
Katarzyna Wrzeszcz, Piotr Rhone, Katarzyna Kwiatkowska, Barbara Ruszkowska-Ciastek. Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival. Life 2023; 13(5): 1106 doi: 10.3390/life13051106
|
| 6 |
Satya Narayan, Srinivasa Ramisetti, Aruna S. Jaiswal, Brian K. Law, Ashona Singh-Pillay, Parvesh Singh, Shantu Amin, Arun K. Sharma. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. European Journal of Medicinal Chemistry 2019; 161: 456 doi: 10.1016/j.ejmech.2018.10.052
|
| 7 |
Lingyu Li, Wei Li, Chang Wang, Xu Yan, Yizhuo Wang, Chao Niu, Xiaoying Zhang, Min Li, Huimin Tian, Cheng Yao, Haofan Jin, Fujun Han, Dongsheng Xu, Wei Han, Dan Li, Jiuwei Cui. Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma. Cytotherapy 2018; 20(1): 134 doi: 10.1016/j.jcyt.2017.09.009
|
| 8 |
Yinan Bao, Si Chen, Ruxin Jiang, Yuewei Li, Lei Chen, Feng Li, Jiandong Tai. The physical activity of colorectal cancer survivors during chemotherapy. Supportive Care in Cancer 2020; 28(2): 819 doi: 10.1007/s00520-019-04873-3
|
| 9 |
Jae Myeong Lee, Hee Cheol Kim, In Ja Park, Dae Dong Kim, Chang Sik Yu, Jin Cheon Kim. The Characteristics of Colorectal Cancer in Patients Older than 80 Years. Journal of the Korean Society of Coloproctology 2007; 23(6): 490 doi: 10.3393/jksc.2007.23.6.490
|
| 10 |
Stefano Fogli, Michele Caraglia. Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives. Expert Opinion on Pharmacotherapy 2009; 10(7): 1095 doi: 10.1517/14656560902889775
|
| 11 |
Yan Zhang, Junli Ma, Sai Zhang, Ganlu Deng, Xiaoling Wu, Jingxuan He, Haiping Pei, Hong Shen, Shan Zeng. A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites. International Journal of Colorectal Disease 2015; 30(9): 1173 doi: 10.1007/s00384-015-2273-z
|
| 12 |
Satya Narayan, Aruna S. Jaiswal, Ritika Sharma, Akbar Nawab, Lizette Vila Duckworth, Brian K. Law, Maria Zajac-Kaye, Thomas J. George, Jay Sharma, Arun K. Sharma, Robert A. Hromas. NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations. Oncotarget 2017; 8(34): 57246 doi: 10.18632/oncotarget.19778
|
| 13 |
Pirita Varpe, Heikki Huhtinen, Arto Rantala, Juha Grönroos. Patient’s age should not play a key role in clinical decisions on surgical treatment of rectal cancer. Aging Clinical and Experimental Research 2010; 22(1): 42 doi: 10.1007/BF03324814
|
| 14 |
Yoshiko Inafuku, Tomohisa Furuhata, Makoto Tayama, Kenji Okita, Toshihiko Nishidate, Toru Mizuguchi, Yasutoshi Kimura, Koichi Hirata. Matrix metalloproteinase‐2 expression in stromal tissues is a consistent prognostic factor in stage II colon cancer. Cancer Science 2009; 100(5): 852 doi: 10.1111/j.1349-7006.2009.01116.x
|
| 15 |
Jens Neumann, David Horst, Lydia Kriegl, Susanne Maatz, Jutta Engel, Andreas Jung, Thomas Kirchner. A simple immunohistochemical algorithm predicts the risk of distant metastases in right‐sided colon cancer. Histopathology 2012; 60(3): 416 doi: 10.1111/j.1365-2559.2011.04126.x
|
| 16 |
Shanthi Sabarimurugan, Chellan Kumarasamy, Madhav Madurantakam Royam, Karthik Lakhotiya, Gothandam Kodiveri Muthukaliannan, Suja Ramalingam, Rama Jayaraj. Validation of miRNA prognostic significance in stage II colorectal cancer. Medicine 2019; 98(12): e14570 doi: 10.1097/MD.0000000000014570
|
| 17 |
Hiba Al Naji, Jean M Winter, Susanne K Pedersen, Amitesh Roy, Susan E Byrne, Graeme P Young, Erin L Symonds. Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer. Biomarker Insights 2024; 19 doi: 10.1177/11772719241232870
|
| 18 |
Takatoshi Matsuyama, Toshiaki Ishikawa, Kaoru Mogushi, Tsuyoshi Yoshida, Satoru Iida, Hiroyuki Uetake, Hiroshi Mizushima, Hiroshi Tanaka, Kenichi Sugihara. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. International Journal of Cancer 2010; 127(10): 2292 doi: 10.1002/ijc.25256
|
| 19 |
C.L. Ringland, H.-T. Arkenau, D.L. O'Connell, R.L. Ward. Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry. Annals of Oncology 2010; 21(1): 92 doi: 10.1093/annonc/mdp288
|
| 20 |
Chi-Jung Huang, Shung-Haur Yang, Chia-Long Lee, Yu-Che Cheng, Szu-Yun Tai, Chih-Cheng Chien, Syed A. Aziz. Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting Prognoses. PLoS ONE 2013; 8(6): e67043 doi: 10.1371/journal.pone.0067043
|
| 21 |
Satya Narayan, Ritika Sharma. Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis. Life Sciences 2015; 139: 145 doi: 10.1016/j.lfs.2015.08.019
|
| 22 |
QIANG ZHANG, JIE YANG, QUN QIAN. Evidence-based treatment of patients with rectal cancer. Oncology Letters 2016; 11(3): 1631 doi: 10.3892/ol.2016.4100
|